RealSelf unveiled the 2019 Worth It Ranking, a comprehensive list that ranks the Worth It Ratings of more than 140 surgical and nonsurgical cosmetic procedures and brands.
The RealSelf Worth It Rating is a proprietary consumer satisfaction score based on reviews from consumers on RealSelf who, after undergoing a treatment, rated it as “Worth It” or “Not Worth It.”
In addition to the full ranking, RealSelf announced the treatments designated as the “Most Worth It” procedures for 2019. The top-ranked surgical procedure was breast implant removal with a 99% Worth It Rating, while diVa Vaginal Therapy, a laser used to address changes in vaginal health often caused by childbirth and menopause, ranked highest for nonsurgical treatments with a 100% Worth It Rating.
Apollo Endosurgery Inc, a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announces the sale of its Surgical product line, which consists of the Lap-Band adjustable gastric banding system and other accessories used in laparoscopic bariatric surgery, to ReShape Lifesciences Inc.
The definitive transaction agreements were signed and closed simultaneously on December 17, 2018.
This transaction will allow Apollo to focus all its efforts on growing the clinical adoption of its Endo-bariatric product offerings, which consists of its OverStitch Endoscopic Suturing Systems and the Orbera Intragastric Balloon technologies.
“Our Surgical product line has served an important purpose for us, but it is no longer a strategic fit with our focus on our Endo-bariatric products and therapies,” states Todd Newton, Apollo’s chief executive officer, in a media release.
“The future for therapeutic endoscopy is very promising, especially due to flexible endoscopic suturing delivered by our OverStitch technology. By allowing physicians to suture with precision and assurance from a flexible endoscope, OverStitch enables many improved core gastrointestinal and bariatric therapy options for physicians and their patients.
“We also remain very bullish on the potential of the intra-gastric balloon market. We believe it is in the best interest of Apollo’s customers and shareholders that we direct our attention exclusively to the growth opportunities being afforded to us from these products.”
At closing Apollo received cash of $10 million and ReShape’s intra-gastric balloon product line. Apollo will also receive payments of $2 million each on the first and second anniversaries of the closing, and a final payment of $3 million on the third anniversary of the closing.
As part of the transaction, Apollo retains a secured interest in the assets of ReShape until the earlier of a) satisfaction of the payments due, or b) the completion by ReShape of a qualifying equity raise of at least $15 million.
Apollo and ReShape also entered into a set of transition services agreements under which Apollo will continue to manufacture the Surgical product line for ReShape for up to 2 years, continue distributing the products in markets outside the United States for up to 12 months, and other specified services.
While the ReShape intra-gastric balloon will remain available for the near term, Apollo intends to focus its commercial efforts exclusively on its Orbera intra-gastric balloon products.
Apollo used the upfront cash proceeds from ReShape of $10 million to pay down its borrowings under its senior secured credit facility.
[Source(s): Apollo Endosurgery Inc, Business Wire]
Botox injections are approved to reduce the frequency of migraine headaches, but studies of their effectiveness have had mixed results. Now a review of studies has concluded that Botox has small but significant benefits, with few serious side effects.
Researchers analyzed data from 17 studies, including 3,646 patients, that tested botulinum toxin injections against placebos. More than 86 percent of the patients were women, and 43 percent had chronic migraines, with more than 15 headache days a month. The analysis is in Plastic and Reconstructive Surgery.
A new survey conducted on behalf of RealSelf by The Harris Poll reveals that 82% of US adults plan to make changes related to their personal well-being and/or appearance in 2019.
Survey respondents note that they plan to exercise more (58%), eat healthier foods (55%), invest more in mental health (33%), and make greater efforts to lose weight (32%).
More than one-third (36%) of US adults are considering one or more cosmetic treatments in the next 12 months. This is more than 60% higher than those who report they have had a cosmetic procedure in the past (22%).
Building on the success of Bellafill, its flagship regenerative biostimulatory product, Suneva Medical Inc has signed new partnership agreements with both Healeon Medical Inc and Puregraft LLC.
These two new partnerships are intended to shape the future of regenerative aesthetics, according to the company in a media release.
“The combination of our world class commercial organization and these unique and innovative aesthetic products strategically positions us for long-term growth as a leader in the regenerative aesthetic market,” says Preston Romm, CEO, Suneva Medical, in the release. “These new products will add significant breadth to Suneva’s product portfolio.”
Suneva’s partnership agreement with Healeon Medical, based in Newbury Park, Calif, is for certain markets on Healeon’s proprietary, cutting-edge PRP technology, featuring an innovative high platelet capture design, as well as for a long-term exclusive relationship on Healeon’s next generation technologies arriving to the aesthetics market mid-2019.
“Healeon Medical has a concentration on the growth of regenerative medicine, making Suneva Medical a great partner as it continues to lead this promising area of aesthetics,” states Jeff Greiner, CEO of Healeon Medical.
Suneva’s second partnership is with Solana Beach, Calif-based Puregraft LLC, which develops products that provide surgeons with purified fat for reinjection. As part of the agreement, Suneva Medical has a distribution partnership with Bimini for certain markets on their proprietary Puregraft fat grafting system for use within the regenerative skin and body care industry and an exclusive relationship on their next generation technology scheduled to launch in early to mid-year 2019, the release continues.
“Suneva Medical is a seamless connection for our Puregraft products and its next-generation technology. We look forward to growing the relationship and working together to shape the global aesthetics market,” comments Brad Conlan, CEO of Puregraft, in the release.
[Source(s): Suneva Medical Inc, PR Newswire]
Skin care used to be simple: Clean hands, wash face, apply moisturizer, the end. Now? Not so much. But just as we’ve collectively become comfortable incorporating essences, toners, serums, oils, masks and more into our routines, a new category of skin care has bubbled to the surface — and it just may be the most confusing one yet. We’re talking about the growing-by-the-second sector of at-home skin-care devices.
Below, we break down exactly what you need to know about each type of tool, including which ones deserve a spot on your bathroom shelf.
Stretch marks are a very common condition the affect 50-90% of men and women. There are several scenarios which can cause them. While they are very easy to get, they are nearly impossible to get rid of.
We will review some of the most common stretch mark treatments.
Just when you think Botched can’t get any more wild, the doctors turn it up a notch.
Ahead of the show’s season five premiere, doctors Terry Dubrow and Paul Nassif shared a few of the craziest surgeries viewers can expect to see.
“I kid you not, this season is really different, for two reasons,” Dubrow tells PEOPLE.
Women in Los Angeles desired a more feminine appearance – bigger lips, slender noses and lifted foreheads, plastic surgeons said. By contrast, New Yorkers sought a more natural look defined by stronger jaws, chins and noses.
But what about Philadelphia?
Botched shows Dr. Terry Dubrow and Dr. Paul Nassif take on patients who have had their plastic surgery go terribly wrong. The show is obviously about medical journeys that can easily lead to high bills.
But does the show foot the bill for the plastic surgery on the show? Here is everything you need to know about whether the show pays the patients, and what happens when the surgeons can’t operate.